Monday June 26th 2017

Biogen’s Tecfidera approved in Europe, first launch expected in Germany

Biogen Idec has received approval to launch its soon-to-be blockbuster multiple sclerosis drug, Tecfidera, in Europe, and plans to begin with a launch in Germany in the coming weeks. Approval was widely expected after a committee of the European Medicines Agency voted in favor of the oral pill last November, but the launch was delayed as the Cambridge, Mass.-based company sought 10 extra years of protection there before generic versions of the drug would be allowed. Besides U.S. approval last March,… (Source: bizjournals.com Health Care:Biotechnology headlines)

Read article here: 

Biogen’s Tecfidera approved in Europe, first launch expected in Germany

Leave a Comment

More from category

Germany’s Merck gets EU backing for oral MS drug
Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…
New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation
MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill
MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Best multiple sclerosis blogs
Best multiple sclerosis blogs

Multiple sclerosis blogs are both helpful and inspirational for people affected by the disease. We have selected the 10 [Read More]